111 Net Profit Margin 2018-2024 | YI

111 net profit margin from 2018 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
111 Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-06-30 $2.05B $-0.05B -2.30%
2024-03-31 $2.06B $-0.05B -2.58%
2023-12-31 $2.11B $-0.06B -2.66%
2023-09-30 $2.09B $-0.04B -1.97%
2023-06-30 $2.05B $-0.04B -2.04%
2023-03-31 $2.03B $-0.05B -2.37%
2022-12-31 $1.96B $-0.06B -3.06%
2022-09-30 $1.96B $-0.06B -3.27%
2022-06-30 $2.01B $-0.09B -4.43%
2022-03-31 $2.02B $-0.10B -4.94%
2021-12-31 $1.95B $-0.11B -5.39%
2021-09-30 $1.84B $-0.11B -5.92%
2021-06-30 $1.67B $-0.09B -5.15%
2021-03-31 $1.43B $-0.07B -5.17%
2020-12-31 $1.26B $-0.07B -5.56%
2020-09-30 $0.99B $-0.07B -6.94%
2020-06-30 $0.80B $-0.07B -8.74%
2020-03-31 $0.69B $-0.07B -10.39%
2019-12-31 $0.57B $-0.07B -12.68%
2019-09-30 $0.45B $-0.07B -15.21%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.057B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00